Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study
Combination therapy with TACE demonstrated enhanced survival benefits for patients with intermediate to advanced HCC, particularly in surgical patients with higher tumor burdens.
Authors
- Chengxiang Guo (ORCID: https://orcid.org/0000-0002-9542-5532)
- Weibo Du (ORCID: https://orcid.org/0000-0001-5779-6159)
- Xueli Bai (ORCID: https://orcid.org/0000-0002-2934-0880)
- Xing Xue (ORCID: https://orcid.org/0000-0003-0987-8656)
- Risheng Que (ORCID: https://orcid.org/0000-0003-3242-5639)
- Min Zhang (ORCID: https://orcid.org/0000-0003-0384-2038)
- Yiwen Chen (ORCID: https://orcid.org/0000-0003-3480-8262)
- Jun Qing Yu (ORCID: https://orcid.org/0000-0001-5008-2153)
- Yan Shen
- Shunliang Gao (ORCID: https://orcid.org/0000-0002-4330-7139)
- Tingbo Liang
- Jian Wu (ORCID: https://orcid.org/0000-0001-6393-3770)
- Wenbo Xiao (ORCID: https://orcid.org/0000-0001-7124-1096)
- Ke Sun (ORCID: https://orcid.org/0000-0002-3789-3143)
Institutions
- Zhejiang Cancer Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/cam4.70633
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China